Unibest 优贝德
← Back to patent-cliff list

Umirolimus

Tier C — Watch / trade

Umirolimus

Biosensors International Group Ltd
Originator
2008
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type

TargetsmTOR

BrandLUMENO、Nobori

Indications (approved)冠状动脉再狭窄

Regional status

US
无进展
2014-08-01
EU
-
China
-
Japan
无进展
2013-06-01

Synthetic routes & intermediates2 routes

Originator routes × 0Optimised (non-patent) × 2Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OptimisedRoute 1Steps 2 · Total yield 0.498g(Umirolimus (Free))
Synthetic routes & intermediates Route 1
CodeCAS No.Intermediate
Umirolimus-001110-80-52-Ethoxyethanol
Umirolimus-002832-53-12,3,4,5,6-Pentafluorobenzenesulfonyl chloride
Umirolimus-0031196708-70-9Pentafluorobenzenesulfonic acid 2-ethoxyethyl ester
Umirolimus-00453123-88-9(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-Dihydroxy-3-[1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2(R)-yl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-3,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-1H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
OptimisedRoute 2Steps 2 · Total yield 1.61g(Umirolimus (Free))
Synthetic routes & intermediates Route 2
CodeCAS No.Intermediate
Umirolimus-001110-80-52-Ethoxyethanol
Umirolimus-00517178-12-02-Ethoxyethyl 4-chlorobenzenesulfonate
Umirolimus-006851536-76-02-Ethoxyethyl trifluoromethanesulfonate
Umirolimus-00453123-88-9(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-Dihydroxy-3-[1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2(R)-yl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-3,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-1H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

Frequently asked questions

What are the approved indications of Umirolimus?

Approved indications include: 冠状动脉再狭窄.

When does the Umirolimus patent expire?

No public expiry year is available for Umirolimus yet; this page updates once verified.

How many synthesis routes are recorded for Umirolimus?

2 synthesis routes are recorded; the shortest is 2 steps with 0.498g(Umirolimus (Free)) total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Umirolimus intermediates?

All intermediates in Umirolimus routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Umirolimus intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-24